Construction of the Therapeutic Alliance Between Inpatient Psychiatric Patients and Nurses

Overview

Clarify the determinants of the construction of a Therapeutic Alliance (AT) between paramedical staff (nurses and caregivers ) and adult patients in a functional unit of full-time general psychiatric Whether the quality of Therapeutic Alliance influences the continued support outpatient , after completion of full-time hospitalization.

Full Title of Study: “Levers and Brakes to the Therapeutic Alliance Between Patients in Hospital Full-time Psychiatric and Nurses and Caregivers”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: January 11, 2018

Detailed Description

This is a prospective, observational, multicenter inpatient units Parisian full time of the Etablissement Public Health White House (spread over 4 sites). The study seeks to collect, on the one hand the level of AT obtained at the end of hospitalization in general adult psychiatry and, secondly, to understand how this one was built. The AT will be measured: – Firstly by the self-administered questionnaire STAR-P, translated into French by the "translation / back-translation" method. – Secondly through semi-structured qualitative interviews, conducted at discharge by a health care setting or a specially trained and who did not participate directly in the patient's care included. Indeed, the questionnaires allow, through scales to measure the AT quantitative way through proposals (items) presented as so, and look for associations with some predefined decisive. However, it is difficult to explore more complex combination of mechanisms. Conducting interviews can meet this goal. An interview grid will be conducted and organized around the search for representations and affects related relational patient / nurse(s) and caregiver(s) in the context of hospital care. The interviews will be recorded and fully transcribed. A thematic analysis will be conducted to identify the objects and themes. The inclusions in this qualitative analysis will stop when reaching the saturation process. In this type of study, it is generally necessary to include thirty people to reach saturation. Finally, semi-structured group interviews (focus group) will be conducted by co-investigators and doctoral student psychologist caregivers with the discussion topic imposed: the AT construction. They will be directed to paramedics caregivers (nurses and caregivers) are not part of the investigation team conducting research but actively involved in care. Their goal will be to harvest their representations regarding the quality of the therapeutic relationship they're trying to build with patients. A focus group will be conducted by site (4 sites), with 5 to 12 volunteers per group.

Clinical Trial Outcome Measures

Primary Measures

  • Therapeutic Alliance score overall with self-administered questionnaire STAR-P
    • Time Frame: day 0
    • AT score overall, committed to using the self-administered questionnaire STAR-P particularly suitable for “patients with severe psychiatric disorders” (Rebecca, 2007).

Secondary Measures

  • Number of patients reviewed in outpatient psychiatric consultation
    • Time Frame: three months after hospital discharge.
  • AT evaluated in patients using semi-structured interviews
    • Time Frame: day 0
    • AT evaluated in patients using semi-structured interviews (20-40 minutes), led with an interview grid: research of representations and affects related relational patient / nurse (s) and caregiver ( s) under hospital care.
  • AT evaluated in / nurse (s) and caregiver(s)
    • Time Frame: month 6
    • AT evaluated in / nurse (s) and caregiver (s), through focus group: Research performances and determinants of therapeutic alliance with caregivers.
  • Determinants of AT studied
    • Time Frame: day 0
    • socio-demographic characteristics (age, sex, socio-professional category (CSP), educational level, profession last exercised, wage level; Marital Status; Place of birth); primary psychiatric diagnosis (ICD-10); Companion diagnostics; Total number of psychiatric hospitalizations prior to the study; which stays in Difficult Patient Unit (UMD) in Free Care, in care without consent, or at the request of a representative of the state); Stay in therapeutic isolation room during hospitalization; Length of hospital stay; Supported by a referent nurse; Highlights in the treatment period and that could presuppose an impact on the quality of care
  • intermediate score STAR-P: score of positive collaboration
    • Time Frame: day 0
  • intermediate scores STAR-P: positive contribution score
    • Time Frame: day 0
  • intermediate scores STAR-P: uncooperative intake score of the nursing team and caregiver
    • Time Frame: day 0

Participating in This Clinical Trial

Inclusion Criteria

  • adult patient (>18 years old) – Adult psychiatric inpatients Exclusion Criteria:

  • Patients carrying perversion disorder or paranoia – Patients trust whose legal representative refuses participation in the survey – patients non covered by the french health system – non consenting patients

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Assistance Publique – Hôpitaux de Paris
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Jean-Manuel Morvillers, PhD, Principal Investigator, centre hospitalier Maison Blanche

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.